Quantitative determination of a Mesalazine using reversed phase high- performance liquid chromatography (RP-HPLC)
Keywords:
mesalazine, RP-HPLC, quantitative determinationAbstract
Mesalazine was quantified in a fast, accurate and sensitive way using reversed-phase high-performance liquid chromatography (RP-HPLC) method. In this method, a separation column of porous silica particles L10 (300 × 4.6mm) was used, the flow rate is 0.8 ml/min, the column temperature is 25 °C, the reagent wavelength is 230 nm, and the injection volume is 20 μl. As for the mobile phase, it consisted of acetonitrile 10% 0.1 and phisphoric acid 0.1% and 90% water and the pH was 4. The method was validated by calculating the recovery that ranged between (95.0457-102.280%), and the correlation coefficient (0.9991) and linearity (20-160 μg/ml).The method was successfully applied for the quantitative determination of the mentioned drug.
Downloads
References
Acharjya, S. K., Sahu, A., Das, S., Sagar, P., & Annapurna, M. M. (2010). Spectrophotometric methods for the determination of MSLalamine in bulk and pharmaceutical dosage forms. Journal of pharmaceutical Education and Research, 1(1), 63.
Bystrowska, B., Nowak, J., & Brandys, J. (2000). Validation of a LC method for the determination of 5-aminosalicylic acid and its metabolite in plasma and urine. Journal of pharmaceutical and biomedical analysis, 22(2), 341-347.
Elbashir, A. A., Altayib Alasha Abdalla, F., & Aboul‐Enein, H. Y. (2015). Host–guest inclusion complex of Mesalazine and β‐cyclodextrin and spectrofluorometric determination of Mesalazine. Luminescence, 30(4), 444-450.
Gotti, R., Pomponio, R., Bertucci, C., & Cavrini, V. (2001). Determination of 5-aminosalicylic acid related impurities by micellar electrokinetic chromatography with an ion-pair reagent. Journal of Chromatography A, 916(1-2), 175-183.
Kanala K , Hwiza NT, Chandu BR, Mukkanti K, Katakam P. An open-label, randomized, crossover bioequivalence study of mesalazine 400 mg tablets in indian healthy volunteers under fasting conditions. Der Pharm Lett.2013; 5(3): pp 465-71.
Kim, S., Wang, N., Li, Y., & He, X. (2016). Electrochemical determination of Mesalazine by using graphene oxide coated with a molecularly imprinted sol–gel. Analytical Methods, 8(43), 7780-7788.
Madhavi V,Panchakshari V, Prathyusha TN, Sekaran CB. Spectrophotometric determination of mesalazine in bulk and tablet dosage forms based on diazocoupling reaction with resorcinol. Inter J Pharm Sci Rev Res.2011; 11(1): pp105-9 .
Nobilis, M., Vybiralova, Z., Sladkova, K., Lisa, M., Holčapek, M., & Květina, J. (2006). High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma. Journal of chromatography A, 1119(1-2), 299-308.
Palumbo, G., Bacchi, S., Primavera, L., Palumbo, P., & Carlucci, G. (2005). A validated HPLC method with electrochemical detection for simultaneous assay of 5‐aminosalicylic acid and its metabolite in human plasma. Biomedical Chromatography, 19(5), 350-354..
Palumbo, G., Carlucci, G., Mazzeo, P., Frieri, G., Pimpo, M. T., & Fanini, D. (1995). Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2, 5-dihydroxybenzoic acid in endoscopie intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection. Journal of pharmaceutical and biomedical analysis, 14(1-2), 175-180.
Prasad, P. R., Karunakar, D., & Devi, B. R. (2022). Analytical method development and validation of allopurinol and related substances by using RP-HPLC in bulk form. International Journal of Health Sciences, 6(S2), 10447–10470. https://doi.org/10.53730/ijhs.v6nS2.7809
Qin, J., Di, X., Wang, X., & Liu, Y. (2015). Development and validation of an LC‐MS/MS method for the determination of Mesalazine in beagle dog plasma and its application to a pharmacokinetic study. Biomedical Chromatography, 29(2), 261-267.
Shahrokhian, S., Hosseini, P., & KCISSlzadeh, Z. (2013). Investigation of the Electrochemical Behavior of Mesalazine on the Surface of a Glassy Carbon Electrode Modified with CNT/PPY Doped by 1, 5‐Naphthalenedisulfonic Acid. Electroanalysis, 25(11), 2481-2491.
Stretch, G. L., Campbell, B. J., Dwarakanath, A. D., Yaqoob, M., Stevenson, A., Morris, A. I., & Rhodes, J. M. (1996). 5‐amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or Mesalazine. Alimentary pharmacology & therapeutics, 10(6), 941-947.
Suandayani, N. K. T. ., Sutapa, G. N. ., & Kasmawan, I. G. A. . (2020). Quality control of X-rays with collimator and the beam alignment test tool. International Journal of Physical Sciences and Engineering, 4(3), 7–15. https://doi.org/10.29332/ijpse.v4n3.468
Sukanya, R., Ramki, S., Chen, S. M., & Karthik, R. (2020). Ultrasound treated cerium oxide/tin oxide (CeO2/SnO2) nanocatalyst: A feasible approach and enhanced electrode material for sensing of anti-inflammatory drug 5-aminosalicylic acid in biological samples. Analytica chimica acta, 1096, 76-88.
Vinoth Kumar, J., Kokulnathan, T., Chen, S. M., Chen, T. W., Elgorban, A. M., Elshikh, M. S., ... & Nagarajan, E. R. (2019). Two-dimensional copper tungstate nanosheets: application toward the electrochemical detection of Mesalazine. ACS Sustainable Chemistry & Engineering, 7(22), 18279-18287.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Zawada E, Chaber EP ,Somogi A, Pawinski T. Development and validation of bromatometric, diazotization and vis-spectrophotometric methods for the determination of mesalazine in pharmaceutical formulation .Acta Polo Pharm .2017 ; 74(2) : pp 401- 4.
Zhang, X., Xuan, Y., Sun, A., Lv, Y., & Hou, X. (2009). Simultaneous determination of isoniazid and p‐aminosalicylic acid by capillary electrophoresis using chemiluminescence detection. Luminescence: The journal of biological and chemical luminescence, 24(4), 243-249.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
